CRISPR stocks sank on news the gene editing tool can veer off target. But that’s hardly news – STAT
STAT |
CRISPR stocks sank on news the gene editing tool can veer off target. But that's hardly news
STAT A letter 1 in Nature Methods pointing out potentially dangerous flaws in the CRISPR-Cas9 genome editing system gave biotech investors a sinking feeling on Tuesday, and stocks in genome-editing companies had the same experience. By the close of trading … CRISPR Gene Editing May Cause Hundreds of Unintended Mutations in DNA CRISPR May Not Be Nearly as Precise as We Thought Crack in CRISPR Facade after Unanticipated In Vivo Mutations Arise |
